Optimizing manufacture of liposomal berberine with evaluation of its antihepatoma effects in a murine xenograft model.
Optimizing manufacture of liposomal berberine with evaluation of its antihepatoma effects in a murine xenograft model.
Yung-Chang Lin,Jhan-Yen Kuo,4 Authors,Hsiao‐Wei Wen
2013 · DOI: 10.1016/j.ijpharm.2012.11.017
International journal of pharmaceutics · 54 Citations
TLDR
It is demonstrated that liposome is a good carrier for berberine to inhibit the tumor growth in HepG2 tumor-bearing mice and reduce the size and weight of tumors as compared with the untreated tumor control group.